查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1935489

全球血管成形術用氣球市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Angioplasty Balloons Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 142 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計血管成形術用氣球市場將從 2025 年的 28.1 億美元成長到 2034 年的 41.3 億美元，2026 年至 2034 年的複合年成長率為 4.38%。

由於心血管疾病盛行率不斷上升以及微創手術日益普及，血管成形術用氣球市場預計將迎來顯著成長。全球人口老化和文明病的增加，使得人們對有效心臟介入治療的需求迅速成長。血管成形術用氣球是治療狹窄或阻塞動脈的關鍵工具，與傳統外科手術相比，它是創傷較小的選擇，因此正引領這一趨勢。球囊技術的創新，例如藥物釋放型球囊和生物可吸收材料，不斷改善治療效果和患者預後。

此外，影像和導管技術的進步正在提高血管成形術的準確性和安全性。即時影像技術的應用提高了血管結構的可見度，使醫護人員能夠進行更精準的介入治療。這一趨勢在需要精準導航的複雜病例中尤其重要。此外，以患者為中心的醫療模式的日益普及也推動了易用型設備的研發，從而改善了患者和醫護人員的手術體驗。

人們對預防醫學和早期療育的日益關注也推動了血管成形術用氣球市場的成長。隨著心血管健康意識的提高，越來越多的患者尋求及時的治療方案，導致血管成形術的數量增加。此外，新興市場醫療基礎設施的不斷完善，也促進了先進醫療技術的普及，進一步推動了市場成長。總之，血管成形術用氣球市場預計將迎來強勁成長，其特點是技術創新、患者療效的改善以及應對日益嚴重的心血管疾病負擔。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球血管成形術用氣球市場（依產品分類）

  • 市場分析、洞察與預測
  • 正常氣球
  • 藥物塗層球囊
  • 切割球囊
  • 球囊導管

5. 全球血管成形術用氣球市場（依應用領域分類）

  • 市場分析、洞察與預測
  • 周邊血管疾病
  • 冠狀動脈血管疾病

6. 全球血管成形術用氣球市場（依最終用途分類）

  • 市場分析、洞察與預測
  • 門診手術中心
  • 醫院
  • 導管室

7. 全球血管成形術用氣球市場（依地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic
    • Boston Scientific Corporation
    • Johnson & Johnson ServicesInc
    • Abbott
    • CR BardInc
    • Spectranetics
    • Terumo Medical Corporation
    • Cardinal Health
    • Biotronik
    • Cook Medical
    • Endocor GmbH
    • B. Braun SE
簡介目錄
Product Code: VMR11210708

The Angioplasty Balloons Market size is expected to reach USD 4.13 Billion in 2034 from USD 2.81 Billion (2025) growing at a CAGR of 4.38% during 2026-2034.

The angioplasty balloons market is poised for significant growth, driven by the rising prevalence of cardiovascular diseases and the increasing adoption of minimally invasive procedures. As the global population ages and lifestyle-related health issues become more prevalent, the demand for effective interventional cardiology solutions is surging. Angioplasty balloons, which are essential for treating narrowed or blocked arteries, are at the forefront of this trend, offering patients a less invasive alternative to traditional surgical methods. Innovations in balloon technology, such as drug-eluting balloons and bioresorbable materials, are enhancing treatment efficacy and patient outcomes.

Moreover, advancements in imaging and catheterization techniques are improving the precision and safety of angioplasty procedures. The integration of real-time imaging technologies allows for better visualization of vascular structures, enabling healthcare professionals to perform interventions with greater accuracy. This trend is particularly relevant in complex cases where precise navigation is critical. Additionally, the growing emphasis on patient-centered care is driving the development of user-friendly devices that enhance the overall procedural experience for both patients and healthcare providers.

The increasing focus on preventive healthcare and early intervention is also contributing to the growth of the angioplasty balloons market. As awareness of cardiovascular health rises, more patients are seeking timely treatment options, leading to an uptick in angioplasty procedures. Furthermore, the expansion of healthcare infrastructure in emerging markets is facilitating access to advanced medical technologies, further propelling market growth. In summary, the angioplasty balloons market is set for robust expansion, characterized by technological innovation, improved patient outcomes, and a commitment to addressing the growing burden of cardiovascular diseases.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Normal Balloons
  • Drug Coated Balloons
  • Cutting Balloons
  • Scoring Balloons

By Application

  • Peripheral Vascular Disease
  • Coronary Vascular Disease
  • By-End-use
  • Ambulatory Surgical Centers
  • Hospitals
  • Cath Labs

COMPANIES PROFILED

  • Medtronic, Boston Scientific Corporation, Johnson Johnson Services, Inc, Abbott, C R Bard, Inc, Spectranetics, Terumo Medical Corporation, Cardinal Health, Biotronik, Cook Medical, Endocor GmbH, B Braun SE

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL ANGIOPLASTY BALLOONS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Normal Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Drug Coated Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Cutting Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Scoring Balloons Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ANGIOPLASTY BALLOONS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Peripheral Vascular Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Coronary Vascular Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ANGIOPLASTY BALLOONS MARKET: BY BY-END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast By-end-use
  • 6.2. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Cath Labs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ANGIOPLASTY BALLOONS MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By By-end-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By By-end-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By By-end-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By By-end-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By By-end-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ANGIOPLASTY BALLOONS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Medtronic
    • 9.2.2 Boston Scientific Corporation
    • 9.2.3 Johnson & Johnson ServicesInc
    • 9.2.4 Abbott
    • 9.2.5 C. R. BardInc
    • 9.2.6 Spectranetics
    • 9.2.7 Terumo Medical Corporation
    • 9.2.8 Cardinal Health
    • 9.2.9 Biotronik
    • 9.2.10 Cook Medical
    • 9.2.11 Endocor GmbH
    • 9.2.12 B. Braun SE